Paul Knight

Q: What is Paul Knight's success rate?

Paul Knight currently has a success rate of 91.96751463987668.

Q: What is the average return of Paul Knight's calls?

Their stock ratings have generated an average return of 39.77972943289196.

Keybanc | Healthcare

Paul Knight is an analyst from Keybanc specializing in the Healthcare sector. Ranked #458 out of 4771 analysts, they have issued 8 stock ratings with a success rate of 91.97% and an average return of 39.78%.

With 8 ratings to date, Paul Knight is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 91.97% and an average return of 39.78%, highlighting promising potential as their track record develops further.

#458

Out of 4771

Total Ratings

+91.97%

Success Rate

+39.78%

Average Return

Recent Ratings Analysis

WST

Buy

Jul 02, 2026

Target

$390.00

Current

$344.25

Performance

-5.88%

Paul Knight rated WST as Overweight on Jul 02, 2026, setting a price target of 390. The stock has underperformed, dropping 5.88% despite the bullish target of 390.

RPID

Buy

May 29, 2026

Target

$5.00

Current

$1.20

Performance

-40.30%

On May 29, 2026, RPID was given a Overweight rating by Paul Knight, with a target price of 5. Despite the Buy call, shares fell from 1.2 to 1.2, challenging the optimistic stance.

CYRX

Buy

May 20, 2026

Target

$17.00

Current

$15.27

Performance

8.53%

CYRX received a Overweight rating from Paul Knight on May 20, 2026, aiming for 17. Momentum has favored the Buy call, with shares climbing from 15.27 to 15.27, rewarding those who trusted the recommendation.

XGN

Buy

Mar 11, 2026

Target

$15.00

Current

$6.97

Performance

124.12%

On Mar 11, 2026, Paul Knight published a Overweight outlook on XGN, with a target of 15. Shares gained 124.12%, underscoring the accuracy of the bullish outlook toward 15.

STVN

Buy

Mar 05, 2026

Target

$37.00

Current

$20.95

Performance

—

Paul Knight on Mar 05, 2026 assigned STVN a Overweight rating, with a price target of 37. The recommendation remains pending validation as shares consolidate around 20.95.

TMO

Buy

Dec 08, 2025

Target

$750.00

Current

$603.18

Performance

6.15%

On Dec 08, 2025, Paul Knight reaffirmed TMO with a Overweight rating, targeting 750. The recommendation was supported by strong follow-through as the stock rose from 603.18 to 603.18.

ATR

Buy

Sep 04, 2025

Target

$220.00

Current

$123.05

Performance

-11.13%

ATR was rated Overweight by Paul Knight on Sep 04, 2025, with a price objective of 220. This case shows how bullish projections can fail, with the stock now below 123.05.

LFCR

Hold

Sep 04, 2025

Target

—

Current

$4.09

Performance

-48.49%

On Sep 04, 2025, Paul Knight initiated coverage on LFCR with a Sector Weight rating and target of null. The rating matched the stock’s inability to hold above 4.09.

HBIO

Hold

Apr 09, 2025

Target

—

Current

$8.15

Performance

77.56%

Paul Knight issued a Sector Weight recommendation for HBIO on Apr 09, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

TECH

Hold

Apr 09, 2025

Target

—

Current

$72.08

Performance

33.31%

On Apr 09, 2025, TECH was evaluated by Paul Knight, who gave a Sector Weight rating and target of null. Investors who stayed in despite the Hold saw upside of 33.31%.

WAT

Buy

Mar 31, 2025

Target

$460.00

Current

$401.64

Performance

8.97%

Paul Knight rated WAT as Overweight on Mar 31, 2025, setting a price target of 460. The call has proven timely, with shares rising 8.97% toward the price target of 460.

LAB

Hold

Feb 27, 2025

Target

—

Current

$0.69

Performance

-34.31%

On Feb 27, 2025, LAB was given a Sector Weight rating by Paul Knight, with a target price of null. The rating provided protection from downside risk as the stock fell to 0.6897.

RVTY

Buy

Feb 03, 2025

Target

$145.00

Current

$120.94

Performance

-2.22%

RVTY received a Overweight rating from Paul Knight on Feb 03, 2025, aiming for 145. Price action was muted, as shares hovered around 120.94 despite the bullish outlook.

DECK

Buy

Jan 23, 2025

Target

$230.00

Current

$79.88

Performance

-63.45%

On Jan 23, 2025, Paul Knight published a Overweight outlook on DECK, with a target of 230. Market action contradicted the Buy thesis, as shares slipped to 79.88.

LULU

Buy

Jan 23, 2025

Target

$420.00

Current

$96.88

Performance

-75.02%

Paul Knight on Jan 23, 2025 assigned LULU a Overweight rating, with a price target of 420. The call has struggled to gain traction, with shares losing 75.02%.

BLFS

Buy

Dec 13, 2024

Target

$33.00

Current

$34.92

Performance

30.79%

On Dec 13, 2024, Paul Knight reaffirmed BLFS with a Overweight rating, targeting 33. The recommendation was supported by strong follow-through as the stock rose from 34.92 to 34.92.

RGEN

Buy

Feb 15, 2024

Target

$220.00

Current

$164.68

Performance

-20.07%

RGEN was rated Overweight by Paul Knight on Feb 15, 2024, with a price objective of 220. This case shows how bullish projections can fail, with the stock now below 164.68.

DHR

Buy

Feb 01, 2024

Target

$290.00

Current

$200.58

Performance

-18.17%

On Feb 01, 2024, Paul Knight initiated coverage on DHR with a Overweight rating and target of 290. The Buy call has yet to be validated as shares remain 89.42 away from the target.

Frequency Asked Questions

Who is Paul Knight?

Paul Knight is an analyst from Keybanc specializing in the Healthcare sector.

What is Paul Knight's success rate?

Paul Knight currently has a success rate of +91.97%.

How many ratings has Paul Knight issued?

Paul Knight has issued 8 stock ratings so far.

What is the average return of Paul Knight's calls?

Their stock ratings have generated an average return of +39.78%.

What is Paul Knight's ranking?

Paul Knight is ranked #458 out of 4771 analysts.

What types of ratings does Paul Knight give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Paul Knight?

You can follow Paul Knight by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Paul Knight?

Their latest rating was a Buy on WST issued on 2026-07-02.